Spots Global Cancer Trial Database for Adult Double Cord Blood Transplant Study
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Adult Double Cord Blood Transplant Study
Official Title: A Phase II Multicenter Trial of Myeloablative Double Unit Umbilical Cord Blood Transplantation (UCBT) in Adults With Hematologic Malignancy
Study ID: NCT00514579
Interventions
Study Description
Brief Summary: The hypothesis of the study is double unit umbilical cord blood transplantation in adults will be associated with a one year survival rate of at least 40%.
Detailed Description:
Eligibility
Minimum Age: 22 Years
Eligible Ages: ADULT
Sex: ALL
Healthy Volunteers: No
Locations
City of Hope, Duarte, California, United States
University of California at Los Angeles, Los Angeles, California, United States
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Blood and Marrow Transplant Program at Northside Hospital, Atlanta, Georgia, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Duke University Medical Center, Durham, North Carolina, United States
Case Western Reserve University, Cleveland, Ohio, United States
Ohio State University Medical Center, Columbus, Ohio, United States
University of Oklahoma, Oklahoma City, Oklahoma, United States
University of Wisconsin-Madison, Madison, Wisconsin, United States
Contact Details
Name: Juliet Barker, MBBS
Affiliation: Memorial Sloan Kettering Cancer Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
